PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
NGS vs. JSPR
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Correlation

The correlation between NGS and JSPR is 0.02, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.0

Performance

NGS vs. JSPR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Natural Gas Services Group, Inc. (NGS) and Jasper Therapeutics, Inc. (JSPR). The values are adjusted to include any dividend payments, if applicable.

-80.00%-60.00%-40.00%-20.00%0.00%20.00%40.00%AugustSeptemberOctoberNovemberDecember2025
45.66%
-73.56%
NGS
JSPR

Key characteristics

Sharpe Ratio

NGS:

2.31

JSPR:

-0.54

Sortino Ratio

NGS:

3.02

JSPR:

-0.18

Omega Ratio

NGS:

1.35

JSPR:

0.97

Calmar Ratio

NGS:

1.67

JSPR:

-0.55

Martin Ratio

NGS:

8.46

JSPR:

-1.78

Ulcer Index

NGS:

12.55%

JSPR:

29.85%

Daily Std Dev

NGS:

45.95%

JSPR:

97.22%

Max Drawdown

NGS:

-89.59%

JSPR:

-97.42%

Current Drawdown

NGS:

-25.45%

JSPR:

-96.53%

Fundamentals

Market Cap

NGS:

$366.59M

JSPR:

$85.51M

EPS

NGS:

$1.28

JSPR:

-$4.75

Total Revenue (TTM)

NGS:

$116.08M

JSPR:

$0.00

Gross Profit (TTM)

NGS:

$51.54M

JSPR:

-$587.00K

EBITDA (TTM)

NGS:

$50.18M

JSPR:

-$49.83M

Returns By Period

In the year-to-date period, NGS achieves a 9.51% return, which is significantly higher than JSPR's -73.34% return.


NGS

YTD

9.51%

1M

18.68%

6M

45.66%

1Y

93.35%

5Y*

20.53%

10Y*

2.93%

JSPR

YTD

-73.34%

1M

-73.57%

6M

-73.56%

1Y

-50.90%

5Y*

N/A

10Y*

N/A

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

NGS vs. JSPR — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

NGS
The Risk-Adjusted Performance Rank of NGS is 9090
Overall Rank
The Sharpe Ratio Rank of NGS is 9595
Sharpe Ratio Rank
The Sortino Ratio Rank of NGS is 9191
Sortino Ratio Rank
The Omega Ratio Rank of NGS is 8888
Omega Ratio Rank
The Calmar Ratio Rank of NGS is 8787
Calmar Ratio Rank
The Martin Ratio Rank of NGS is 8989
Martin Ratio Rank

JSPR
The Risk-Adjusted Performance Rank of JSPR is 1717
Overall Rank
The Sharpe Ratio Rank of JSPR is 1818
Sharpe Ratio Rank
The Sortino Ratio Rank of JSPR is 2727
Sortino Ratio Rank
The Omega Ratio Rank of JSPR is 2626
Omega Ratio Rank
The Calmar Ratio Rank of JSPR is 1414
Calmar Ratio Rank
The Martin Ratio Rank of JSPR is 22
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

NGS vs. JSPR - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for Natural Gas Services Group, Inc. (NGS) and Jasper Therapeutics, Inc. (JSPR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for NGS, currently valued at 2.31, compared to the broader market-2.000.002.004.002.31-0.54
The chart of Sortino ratio for NGS, currently valued at 3.02, compared to the broader market-4.00-2.000.002.004.006.003.02-0.18
The chart of Omega ratio for NGS, currently valued at 1.35, compared to the broader market0.501.001.502.001.350.97
The chart of Calmar ratio for NGS, currently valued at 3.71, compared to the broader market0.002.004.006.003.71-0.55
The chart of Martin ratio for NGS, currently valued at 8.46, compared to the broader market0.0010.0020.0030.008.46-1.78
NGS
JSPR

The current NGS Sharpe Ratio is 2.31, which is higher than the JSPR Sharpe Ratio of -0.54. The chart below compares the historical Sharpe Ratios of NGS and JSPR, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.004.005.00AugustSeptemberOctoberNovemberDecember2025
2.31
-0.54
NGS
JSPR

Dividends

NGS vs. JSPR - Dividend Comparison

Neither NGS nor JSPR has paid dividends to shareholders.


Tickers have no history of dividend payments

Drawdowns

NGS vs. JSPR - Drawdown Comparison

The maximum NGS drawdown since its inception was -89.59%, smaller than the maximum JSPR drawdown of -97.42%. Use the drawdown chart below to compare losses from any high point for NGS and JSPR. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%AugustSeptemberOctoberNovemberDecember20250
-96.53%
NGS
JSPR

Volatility

NGS vs. JSPR - Volatility Comparison

The current volatility for Natural Gas Services Group, Inc. (NGS) is 13.52%, while Jasper Therapeutics, Inc. (JSPR) has a volatility of 94.88%. This indicates that NGS experiences smaller price fluctuations and is considered to be less risky than JSPR based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%20.00%40.00%60.00%80.00%100.00%AugustSeptemberOctoberNovemberDecember2025
13.52%
94.88%
NGS
JSPR

Financials

NGS vs. JSPR - Financials Comparison

This section allows you to compare key financial metrics between Natural Gas Services Group, Inc. and Jasper Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


Values in USD except per share items
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab